Showing results (621-630 of 1,995) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|April 28, 2022
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
The Lancet. Neurology|July 8, 2019
Recent developments in drug-induced movement disorders: a mixed pictureStewart A Factor, Pierre R Burkhard, Stanley Caroff, et al.
The Lancet. Neurology|January 22, 2022
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trialsEmmanuel Mignot, David Mayleben, Ingo Fietze, et al.
The Lancet. Neurology|January 22, 2022
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validationStefania Galimberti, Francesca Graziano, Andrew I R Maas, et al.
The Lancet. Neurology|January 22, 2022
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disordersAnna Rostedt Punga, Paul Maddison, Jeannine M Heckmann, et al.
The Lancet. Neurology|March 19, 2022
Casemix, management, and mortality of patients rreseceiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort studyDavid Clark, Alexis Joannides, Amos Olufemi Adeleye, et al.
The Lancet. Neurology|March 19, 2022
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational studyEstrella Morenas-Rodríguez, Yan Li, Brigitte Nuscher, et al.
The Lancet. Neurology|September 17, 2018
Circadian and circaseptan rhythms in human epilepsy: a retrospective cohort studyPhilippa J Karoly, Daniel M Goldenholz, Dean R Freestone, et al.
The Lancet. Neurology|September 24, 2018
Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysisCaterina Fusilli, Simone Migliore, Tommaso Mazza, et al.
The Lancet. Neurology|September 3, 2018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, María Carmona-Iragui, Bessy Benejam, et al.
Pageof 200